Author

Lorenzo Giorio

Observed name: L Giorio

Institution: KU Leuven

Observed institutions: University of Trieste, KU Leuven

ORCID: 0000-0001-8490-0150

Observed ORCID: 0000-0001-8490-0150

OpenAlex ID: A5035458475

Patient-derived organoids for therapy personalization in inflammatory bowel diseases

2022 · Marianna Lucafò, Antonella Muzzo, et al. · World Journal of Gastroenterology · 34

PDF

Dietary Carrageenan Amplifies the Inflammatory Profile, but not Permeability, of Intestinal Epithelial Cells from Patients With Crohn’s Disease

2024 · Eva Vissers, Judith Wellens, et al. · Inflammatory Bowel Diseases · 12

PDF

P111 Dietary emulsifier κ-carrageenan does not directly affect intestinal permeability in organoid-derived epithelial monolayers from patients with Crohn’s disease

2024 · E Vissers, K Arnauts, et al. · Journal of Crohn s and Colitis · 1

PDF

Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses

2026 · Lorenzo Giorio, Steve De Vos, et al. · Journal of Crohn s and Colitis

Unravelling a Hidden Subtype: Multiomics Reveal Psoriasis-like Signature With Surgical Relevance in a Subset of Perianal Fistulizing Crohn’s Disease

2026 · Saeed Abdurahiman, João Sabino, et al. · bioRxiv (Cold Spring Harbor Laboratory)

PDF

Su1497 MUCOSAL TRANSCRIPTOMICS UNCOVER DISTINCT MOLECULAR PATHWAYS DRIVING DISEASE ACTIVITY AND PROGNOSTIC SEVERITY IN ULCERATIVE COLITIS

2026 · Anna-Teresa D’Hooghe, Saeed Abdurahiman, et al. · Gastroenterology

Mo1470 DISEASE DURATION SHAPES IMMUNE SIGNATURES AND REVEALS NEW THERAPEUTIC WINDOWS IN ULCERATIVE COLITIS

2026 · Lorenzo Giorio, Kaline Arnauts, et al. · Gastroenterology

Mo1506 DISTINCT EPITHELIAL REMODELLING PROGRAMS DIFFERENTIALLY ASSOCIATE WITH SURGICAL REPAIR FEASIBILITY AND INDICATE MOLECULAR POTENTIAL TO REFINE CLINICAL ASSESSMENT THROUGH MOLECULAR STRATIFICATION

2026 · Saeed Abdurahiman, João Sabino, et al. · Gastroenterology

2026 · Saeed Abdurahiman, João Sabino, et al. · Gastrointestinal Endoscopy

Sa1443 RESTORING EPITHELIAL BALANCE: UPADACITINIB AMELIORATES INFLAMMATORY, ENDOPLASMIC RETICULUM STRESS AND FIBROSIS SIGNALING IN ULCERATIVE COLITIS

2026 · Lorenzo Giorio, Kaline Arnauts, et al. · Gastroenterology

Su1497 MUCOSAL TRANSCRIPTOMICS UNCOVER DISTINCT MOLECULAR PATHWAYS DRIVING DISEASE ACTIVITY AND PROGNOSTIC SEVERITY IN ULCERATIVE COLITIS

2026 · Anna-Teresa D’Hooghe, Saeed Abdurahiman, et al. · Gastrointestinal Endoscopy

Mo1470 DISEASE DURATION SHAPES IMMUNE SIGNATURES AND REVEALS NEW THERAPEUTIC WINDOWS IN ULCERATIVE COLITIS

2026 · Lorenzo Giorio, Kaline Arnauts, et al. · Gastrointestinal Endoscopy

Sa1443 RESTORING EPITHELIAL BALANCE: UPADACITINIB AMELIORATES INFLAMMATORY, ENDOPLASMIC RETICULUM STRESS AND FIBROSIS SIGNALING IN ULCERATIVE COLITIS

2026 · Lorenzo Giorio, Kaline Arnauts, et al. · Gastrointestinal Endoscopy

P0111 Differential ex vivo responses to GLPG3970 in bio-naive and bio-experienced biopsies from patients with UC

2026 · K Arnauts, L Giorio, et al. · Journal of Crohn s and Colitis

P0046 From stress to healing: upadacitinib ameliorates epithelial endoplasmic reticulum stress and suppresses pro-fibrotic signalling in ulcerative colitis

2026 · L Giorio, K Arnauts, et al. · Journal of Crohn s and Colitis

DOP049 Transcriptomic profiling reveals divergent molecular pathways underlying Ulcerative Colitis disease activity and prognostic severity

2026 · A T D’hooghe, S Abdurahiman, et al. · Journal of Crohn s and Colitis

P0095 Evolving immune signatures with disease duration reveal new therapeutic windows in ulcerative colitis

2026 · K Arnauts, L Giorio, et al. · Journal of Crohn s and Colitis

P0123 Therapy shapes disease: Biologic exposure drives extracellular matrix reprogramming in ulcerative colitis

2026 · L Giorio, K Arnauts, et al. · Journal of Crohn s and Colitis

P0121 Molecular Signatures of Epithelial Remodelling Associate with Surgical Repair Feasibility and Ileostomy Risk in Perianal Fistulising Crohn’s disease

2026 · S Abdurahiman, J Guedelha Sabino, et al. · Journal of Crohn s and Colitis

Mo1994: THE DIETARY EMULSIFIER κ-CARRAGEENAN ALTERS THE INFLAMMATORY STATE, BUT NOT PERMEABILITY, OF INTESTINAL EPITHELIAL CELLS FROM PATIENTS WITH CROHN’S DISEASE

2025 · Eva Vissers, Judith Wellens, et al. · Gastroenterology

Mo1995: IMPROVED MODELING OF INFLAMMATORY BOWEL DISEASE USING ER STRESS- AND INFLAMMATION-PRIMED DIFFERENTIATED INTESTINAL ORGANOIDS

2025 · Lorenzo Giorio, Kaline Arnauts, et al. · Gastroenterology

P0098 Effect of the dietary emulsifier κ-carrageenan on the inflammatory state and permeability of intestinal epithelial cells from patients with Crohn’s disease

2025 · E Vissers, J Wellens, et al. · Journal of Crohn s and Colitis

DOP110 Optimized inflammatory and ER stress-induced phenotypes in differentiated intestinal organoids for modelling Inflammatory Bowel Disease

2025 · L Giorio, K Arnauts, et al. · Journal of Crohn s and Colitis

Works count: 23

Citation count: 47

H-index: 2

I10-index: 2